How enlightened self-interest guided global vaccine sharing benefits all: a modelling study (preprint)

Background: Despite the consensus that vaccines play an important role in combating the global spread of infectious diseases, vaccine inequity is still rampant with deep-seated mentality of self-priority. This study aims to evaluate the existence and possible outcomes of a more equitable global vaccine distribution and explore a concrete incentive mechanism that promotes vaccine equity. Methods: We design a metapopulation epidemiological model that simultaneously considers global vaccine distribution and human mobility, which is then calibrated by the number of infections and real-world vaccination records during COVID-19 pandemic from March 2020 to July 2021. We explore the possibility of the enlightened self-interest incentive mechanism, i.e., improving one's own epidemic outcomes by sharing vaccines with other countries, by evaluating the number of infections and deaths under various vaccine sharing strategies using the proposed model. To understand how these strategies affect the national interests, we distinguish the imported and local cases for further cost-benefit analyses that rationalize the enlightened self-interest incentive mechanism behind vaccine sharing. ...

Strategic COVID-19 vaccine distribution can simultaneously elevate social utility and equity (preprint)

Balancing social utility and equity in distributing limited vaccines represents a critical policy concern for protecting against the prolonged COVID-19 pandemic. What is the nature of the trade-off between maximizing collective welfare and minimizing disparities between more and less privileged communities? To evaluate vaccination strategies, we propose a novel epidemic model that explicitly accounts for both demographic and mobility differences among communities and their association with heterogeneous COVID-19 risks, then calibrate it with large-scale data. Using this model, we find that social utility and equity can be simultaneously improved when vaccine access is prioritized for the most disadvantaged communities, which holds even when such communities manifest considerable vaccine reluctance. Nevertheless, equity among distinct demographic features are in tension due to their complex correlation in society. We design two behavior-and-demography-aware indices, community risk and societal harm, which capture the risks communities face and those they impose on society from not being vaccinated, to inform the design of comprehensive vaccine distribution strategies. Our study provides a framework for uniting utility and equity-based considerations in vaccine distribution, and sheds light on how to balance multiple ethical values in complex settings for epidemic control.

Policy-Aware Mobility Model Explains the Growth of COVID-19 in Cities (preprint)

With the continued spread of coronavirus, the task of forecasting distinctive COVID-19 growth curves in different cities, which remain inadequately explained by standard epidemiological models, is critical for medical supply and treatment. Predictions must take into account non-pharmaceutical interventions to slow the spread of coronavirus, including stay-at-home orders, social distancing, quarantine and compulsory mask-wearing, leading to reductions in intra-city mobility and viral transmission. Moreover, recent work associating coronavirus with human mobility and detailed movement data suggest the need to consider urban mobility in disease forecasts. Here we show that by incorporating intra-city mobility and policy adoption into a novel metapopulation SEIR model, we can accurately predict complex COVID-19 growth patterns in U.S. cities ($R^2$ = 0.990). Estimated mobility change due to policy interventions is consistent with empirical observation from Apple Mobility Trends Reports (Pearson's R = 0.872), suggesting the utility of model-based predictions where data are limited. Our model also reproduces urban "superspreading", where a few neighborhoods account for most secondary infections across urban space, arising from uneven neighborhood populations and heightened intra-city churn in popular neighborhoods. Therefore, our model can facilitate location-aware mobility reduction policy that more effectively mitigates disease transmission at similar social cost. Finally, we demonstrate our model can serve as a fine-grained analytic and simulation framework that informs the design of rational non-pharmaceutical interventions policies.